BRYET US

BrYet is a privately-owned biotech company focused on the discovery and development of novel physics-based, first-in-class therapies for metastatic liver and lung cancers... BrYet has developed a therapeutic agent with unprecedented curative potential for metastases to the lung and liver... Thirty years ago, we also recognized that the world of oncology largely classified and treated metastatic cancers by association with the organ of origin - thus, a breast cancer with metastasis was classified as breast cancer, and treated accordingly. Nothing has changed since. Maybe, this paradigm is a key reason why progress in the fight against these deadly forms of cancer has been so excruciatingly inadequate.

Also known as: BrYet, BrYet US, Inc.

Primary location: Houston United States